ASX Filings
Read about Tryptamine Therapeutics Limited on the ASX
Previous Press Releases of Tryp
on the Canadian securities exchange
Read about Tryp Therapeutics on Sedar
All News
See below for a comprehensive list of news items published by Tryp Therapeutics.
Tryp Therapeutics Announces 99.92% Votes Cast By Shareholders In Favor Of Arrangement Agreement At Annual General And Special Meeting Of Securityholders, And Receipt Of Final Order
March 12, 2024 Kelowna, Canada – March 12, 2024 – Tryp Therapeutics, Inc. (“Tryp” or the “Company”) (CSE: TRYP, OTCQB:…
Tryp Therapeutics And Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
January 26, 2024 Kelowna, Canada – January 26, 2024 – Tryp Therapeutics, Inc. (“Tryp” or the “Company”) (ASX: TYP), a…
Tryp Therapeutics Announces Significant Milestone In Its Clinical Trial Program For Trp[1]8803 (Iv-Infused Psilocin)
January 8, 2024 Kelowna, Canada – January 8, 2024 – Tryp Therapeutics, Inc. (“Tryp” or the “Company”) (CSE: TRYP,OTCQB: TRYPF),…
Tryp Therapeutics Announces First Patient Dosed In Phase 2a Clinical Trial For The Treatment Of Fibromyalgia At The University Of Michigan
January 4, 2024 Kelowna, Canada – January 4, 2024 – Tryp Therapeutics Inc. (“Tryp” or the “Company”) (CSE: TRYP), a…
Tryp Therapeutics Inc. Announces Signing of Definitive Agreement with Exopharm Limited
DECEMBER 13, 2023 KELOWNA, BC / ACCESSWIRE / December 11, 2023 / Tryp Therapeutics Inc. (“Tryp” or the “Company“) (CSE:TRYP), a…
Tryp Therapeutics Announces Closing of Oversubscribed Private Placement of Unsecured Convertible Notes for Gross Proceeds of AUD$3,215,000
January 8, 2024 Kelowna, Canada – January 8, 2024 – Tryp Therapeutics, Inc. (“Tryp” or the “Company”) (CSE: TRYP, OTCQB:…